You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adoptive T cell therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

Not yet recruiting
  • Lupus Nephritis
  • Type 1 Diabetes Mellitus
  • autologous adoptive T regulatory cell transfer.
  • Cairo, Egypt
    Ain shams university, faculty of medicine
Sep 30, 2022

Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount

Recruiting
  • Triple Negative Breast Cancer
  • Nonsmall Cell Lung Cancer
    • Rocky Mount, North Carolina
      Accellacare of Rocky Mount -Dr. Bondy
    May 26, 2023

    Metastatic Melanoma Trial in Tampa (procedure, drug, other)

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • Surgery
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023

    Solid Tumor Trial in United States (NeoTCR-P1 adoptive cell therapy, nivolumab, IL-2)

    Suspended
    • Solid Tumor
    • NeoTCR-P1 adoptive cell therapy
    • +2 more
    • Duarte, California
    • +8 more
    Aug 16, 2022

    Tumors Trial in Worldwide (GSK adoptive cell therapy)

    Recruiting
    • Neoplasms
    • GSK adoptive cell therapy
    • Duarte, California
    • +37 more
    Feb 1, 2022

    Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

    Not yet recruiting
    • Cancer
      • (no location specified)
      Feb 7, 2023

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Active, not recruiting
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +11 more
      • Aldesleukin
      • +3 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 13, 2022

      SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

      Recruiting
      • COVID-19
      • Blood donation from convalescent donor
      • Singapore, Singapore
      • +1 more
      Mar 29, 2022

      Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix (Autologous MUC1-activated T-cells,

      Recruiting
      • Recurrent Plasma Cell Myeloma
      • Refractory Plasma Cell Myeloma
      • Phoenix, Arizona
        Mayo Clinic Hospital in Arizona
      Jan 4, 2023

      Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • iNKT Cells
      • +2 more
      • Beijing, Beijing, China
        Beijing Youan Hospital,Capital Medical University
      Jul 24, 2023

      Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

      Recruiting
      • Acute Myeloid Leukemia
      • Graft cell infusion
      • +6 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 29, 2023

      Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

      Not yet recruiting
      • Advanced Melanoma
      • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
      • Basel, Switzerland
        University Hospital Basel
      May 19, 2023

      Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

      Active, not recruiting
      Has Results
      • Metastatic Melanoma
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Nov 8, 2022

      Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

      Recruiting
      • Non-hodgkin Lymphoma,B Cell
      • Autologous CD19-STAR-T cell
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Nov 21, 2022

      ASCT Versus Chemotherapy as First-Line Consolidation Therapy

      Completed
      • T-cell Lymphoma Adults
      • consolidation with ASCT
      • (no location specified)
      Nov 25, 2023

      Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

      Not yet recruiting
      • Cancer
      • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
      • Fludarabine (30 mg/m^2)
      • +2 more
      • (no location specified)
      Jul 25, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      Aug 7, 2023

      Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

      Recruiting
      • Leukemia
      • Lymphoma
      • SCRI-CAR22v2
      • Los Angeles, California
      • +4 more
      Jan 18, 2023

      Colorectal Adenocarcinoma, Metastatic Cholangiocarcinoma, Metastatic Colorectal Carcinoma Trial in Houston (biological, drug,

      Terminated
      • Colorectal Adenocarcinoma
      • +12 more
      • Adoptive Immunotherapy
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 28, 2020

      B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • +2 more
      • CD19/CD22-bispecific CAR-T cells
      • Beijing, Beijing, China
        Liang Wang
      Oct 7, 2023

      Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

      Recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)

      Recruiting
      • Multiple Sclerosis
      • Cellular therapy with EBV specific autologous CTL infusion
      • Nantes, France
        University Hospital
      Jan 27, 2021

      Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

      Not yet recruiting
      • Synovial Sarcoma
      • Fludarabine phosphate
      • +2 more
      • Houston, Texas
        MD Anderson Cancer Center
      Oct 9, 2023

      Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • Bone Sarcoma
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 10, 2022

      Harvesting Cells for Experimental Cancer Treatments

      Enrolling by invitation
      • Melanoma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 6, 2023